title: Alternating combination of alkylating agents and vincristine, doxorubicin, and dexamethasone in multiple myeloma.
authors.forename: C
authors.initials: C
authors.lastname: Lejeune
authors.forename: J J
authors.initials: JJ
authors.lastname: Sotto
authors.forename: J G
authors.initials: JG
authors.lastname: Fuzibet
authors.forename: J F
authors.initials: JF
authors.lastname: Rossi
authors.forename: G
authors.initials: G
authors.lastname: Lepeu
authors.forename: R
authors.initials: R
authors.lastname: Bataille
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D006801:Humans; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D015996:Survival Rate; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin